Akero Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: AKRO on Nasdaq
Industry: Pharmaceutical Preparations
Location: 601 Gateway Boulevard, Suite 350, South San Francisco, CA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+400K	24.9%	$45.97	+$18.4M
Sells	6	-1.2M	75.1%	$35.86	-$43.2M
Net	-5	-804K	-50.1%		-$24.8M

Akero Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
G. Walmsley Graham	Director	$52.4M	+$18.4M	+54.1%	Mar 25, 2025
Andrew Cheng	President and CEO, Director	$22M	-$13.2M	-37.5%	Apr 10, 2025
Jonathan Young	Chief Operating Officer	$18.3M	-$7.23M	-28.3%	Mar 12, 2025
Timothy Rolph	Chief Scientific Officer	$6.43M	-$3.94M	-38%	Apr 7, 2025
Catriona Yale	Chief Development Officer	$3.67M	-$10.2M	-73.5%	Apr 15, 2025
William Richard White	Chief Financial Officer	$2.78M	-$8.21M	-74.7%	Mar 12, 2025
Skorpios Trust	Former 10% owner	$2.01M			Dec 1, 2022
Patrick Lamy	Senior VP, Commercial Strategy	$1.61M	-$404K	-20%	Mar 3, 2025
Scott A. Gangloff	Chief Technology Officer	$756K			Dec 16, 2024
Mark T. Iwicki	Director				Jun 8, 2024
ATP Life Science Ventures, L.P.	10%+ Owner				Jun 28, 2021
Tomas J. Heyman	Director				Jun 8, 2024
Chou Judy	Director				Jun 8, 2024
Yuan Xu	Director				Jun 8, 2024
Jane Henderson	Director				Jun 8, 2024
Seth Loring Harrison	Director				Jun 8, 2024
Kevin Bitterman	Director				Jun 1, 2021

Recent Insider Transactions by Companies or Individuals for Akero Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.